Impact of a Combined VBID & Medication Therapy Management Program on Diabetes Medication Adherence

November 1, 2016

Value-based insurance design (VBID) waives or reduces prescription copayments in order to decrease member cost barriers to refilling medications. Medication therapy management (MTM) is a member clinical intervention designed to reinforce members’ knowledge of their medications, which addresses barriers to medication adherence. Both methods have been shown to increase adherence in members, particularly when used in combination. To date, studies of such combined programs have often been completed within integrated health systems but have rarely included control populations.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navigating with a trusted partner

Now Available: 9th Annual Drug Trend Report

Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.

Related blogs

Navigating Healthcare and Improving Outcomes

Navigating the Key Drivers of Drug Spend and Utilization

Navigating the Key Drivers of Drug Spend and Utilization

Prescription drug spending rose by 11.4% in 2024, reshaping how plan sponsors approach their pharmacy benefit strategy. Costs climbed as existing therapies expanded, new treatments entered the market and coverage decisions shifted pricing dynamics. For…

previous arrow
next arrow